A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

clinical trial

Details

Instance of: clinical trial
Start time: October 2002
End time: November 2006
Country: United States
Main subject: esophagitis, eosinophilic esophagitis
clinical trial phase: phase III clinical trial
maximum age: 30
minimum age: 3
number of participants: 30
research site: Cincinnati Children's Hospital Medical Center
study type: interventional study
title: Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial

Nothing in the MetaHistoryBook collection references this item yet.